The human host response to TB is still being characterized, and—although there are some clearly defined examples of immune modulation leading to active disease (i.e., use of anti-TNF antibodies, advanced HIV, and older age)—the clinical effects of immune deviation as a consequence of concurrent helminth infection have not been fully elucidated. This evidence concerns the gene TNF and helminthiasis.